INVESTMENT TEAM

David J. Brailer, MD, PhD
David J. Brailer, MD, PhD is Chairman of Health Evolution Partners. Dr. Brailer has sought to drive positive change in health care in his work as a physician, researcher, teacher, entrepreneur and policymaker. Dr. Brailer founded CareScience, Inc. and served as Chairman and CEO from inception, through its IPO, and until its sale in 2002. Under his leadership, CareScience led the market in development of care management, outcomes analysis and health information exchange. In 2004, Dr. Brailer was appointed by President George W. Bush as the first National Coordinator for Health Information Technology. In this role, Dr. Brailer developed and led the nation’s strategy for ushering health care into the digital era.

Dr. Brailer earned his MD at West Virginia University, completed his internal medicine residency at the University of Pennsylvania School of Medicine, and earned his PhD in health economics at The Wharton School. Dr. Brailer taught in Wharton’s MBA curriculum for ten years.

Adam Grossman
Adam Grossman is a Principal focusing on the Growth Fund at Health Evolution Partners. Mr. Grossman has over a decade of health care experience as an investor, operator and consultant. He led health care investing for Aetna as a Managing Director and Founder of Aetna Ventures. Prior to Aetna, Mr. Grossman was a management consultant at McKinsey & Co. His operating experience includes being a founding member of Principalcare, a physician practice management company, and a member of the business development team at MedAlliance, previously known as ImageAmerica.

Mr. Grossman graduated from Dartmouth College with a bachelor's degree in Government and received his MBA from Harvard Business School.

Braden Kelly
Braden Kelly is a Senior Advisor focusing on the Growth Fund at Health Evolution Partners. Mr. Kelly served as a Partner and Managing Director of General Atlantic, a global private equity investment firm. Mr. Kelly was with General Atlantic from 1995 until his retirement at the end of 2006. Mr. Kelly served as head of General Atlantic’s Palo Alto office and global health care practice, and as a member of its Investment Committee. He has served on public and private boards of technology, health care technology and health care services companies. Prior to joining General Atlantic, Mr. Kelly worked in the Investment Banking division at Morgan Stanley & Co.

Mr. Kelly graduated with highest honors from the University of Notre Dame and received a Bachelors of Business Administration degree in Finance and Business Economics.

Brian Kirkbride
Brian Kirkbride is a Principal in the Growth Fund at Health Evolution Partners. Mr. Kirkbride has over 10 years of health care experience as an investor, operator and investment banker. He was Chief Operating Officer of Kalologie, a cosmetic dermatology company. Prior to that, he was an investment professional in the health care practice at Highland Capital Partners. Previously, he was a co-founding member of the health care group at Thomas Weisel Partners and a health care investment banker at Raymond James & Associates.

Mr. Kirkbride graduated magna cum laude from Vanderbilt University, where he earned Honors in Economics and was elected to Phi Beta Kappa. He received an MBA from Harvard Business School.

Christopher McFadden
Chris McFadden is a Managing Director focusing on the Growth Fund at Health Evolution Partners. Mr. McFadden has over 12 years of health care industry experience as a research analyst and investor. Prior to joining Health Evolution Partners, he was a Managing Director at Goldman Sachs. directing debt and equity investments in private and public North American-based health care companies as part of the Americas Special Situations Group. From 1999 to 2007, Mr. McFadden was a senior equity analyst responsible for Goldman Sachs’ US health care services research coverage and served as a member of the Global Investment Research Sounding Board. Prior to joining Goldman Sachs, he worked as a senior research analyst at Wheat First Securities, now Wachovia Securities. Prior to that, he held marketing and management positions at Xerox Corporation.

Mr. McFadden received his bachelor’s degree in Political Science from the University of Richmond and studied graduate Economics at Virginia Commonwealth University. Mr. McFadden became a Chartered Financial Analyst (CFA) in 1999.

Ian McKelvie
Ian McKelvie is a Senior Associate focusing on the Growth Fund at Health Evolution Partners. Prior to Health Evolution Partners, Mr. McKelvie worked as an Associate focused on health care at Arsenal Capital Partners. Before that he worked as a Senior Analyst in the Healthcare Investment Banking Group of Banc of America Securities.

Mr. McKelvie received his bachelor’s degree in Business Administration from the University of North Carolina at Chapel Hill and is currently a second year MBA student at the Stanford Graduate School of Business.

Carter Paine
Carter Paine is a Senior Associate focusing on the Growth Fund at Health Evolution Partners. Mr. Paine began his career as an investment banker at Robertson Stephens and was an Associate in the Health Care Services Group at Jefferies and Company, where he managed all stages of transactions across a broad range of health care services sectors. During business school, Mr. Paine worked at SV Life Sciences, a health care focused venture capital firm, and also worked in the Corporate Development Group at Healthways.

Mr. Paine graduated from the McIntire School at the University of Virginia, earning a Bachelor of Science in Commerce, with a concentration in finance. He received an MBA from the Wharton School at the University of Pennsylvania, majoring in health care management.

Jerrold Wong
Jerrold Wong is an Associate focusing on the Growth Fund at Health Evolution Partners. Prior to joining Health Evolution Partners, Mr. Wong worked in the Mergers & Acquisitions Group of UBS Investment Bank, where he executed a number of transactions across a broad range of industries, including health care. In addition to UBS Investment Bank, Mr. Wong's prior experience includes working in the Mergers & Acquisitions Group of Merrill Lynch and Blackrock Financial Management.

Mr. Wong received his bachelor's degree from Columbia University, graduating cum laude with a double major in Economics and East Asian Languages and Cultures.

Jeff Yang
Jeff Yang is an Associate focusing on the Growth Fund at Health Evolution Partners. Mr. Yang began his career in the Health Care Investment Banking group at Deutsche Bank, where he was a key team member on several significant transactions and client relationships. At Deutsche Bank, he also served on a committee responsible for developing standardized templates and best practices throughout the firm.

Mr. Yang graduated from the Ross School of Business at the University of Michigan, earning a Bachelor of Business Administration degree with concentrations in finance and accounting.

Roy Ziegler
Roy Ziegler leads HEPIN and is responsible for venture stage investment activities at Health Evolution Partners. He has been in the health care information technology industry for over 25 years in consulting, entrepreneurial, operating and investment roles across the provider, payer and life sciences sectors. Prior to Health Evolution Partners, Mr. Ziegler was a venture partner with Partech International focused on health care information technology early stage investing. Previously, he was an Executive Vice President at First Consulting Group (FCG) and was responsible for new business practices, managing large P&L’s, and making acquisitions to broaden the services portfolio. Mr. Ziegler led the company to over 40% CAGR and a successful IPO. Prior to joining FCG, he spent ten years at Accenture, where he worked on IT strategies and implementing software and enabling technologies in the health care industry.

Mr. Ziegler graduated cum laude from Pepperdine University where he received a bachelor's degree in Business Administration.

ADMINISTRATIVE TEAM

Nina Labatt
Nina Labatt is Chief Financial Officer responsible for financial management and reporting. She currently serves on the board of directors of the VCBC, the industry association for venture capital finance professionals. Before joining Health Evolution Partners, Ms. Labatt spent five years in a similar role at Labrador Ventures. Previously, she spent six years at Goldman Sachs. in New York where she worked in various Investment Banking Division departments, including Corporate Finance, Mergers and Acquisitions, Capital Markets, and Principal Investing. She spent one additional year in Corporate Finance with Montgomery Securities before moving into operations management for Nice Ventures where she was CFO, PeoplePC where she was Director of Operations at the time of its IPO, and Saints Ventures where she was a Managing Director, COO and CFO.

Ms. Labatt received her bachelor’s degree in Economics with Honors and her master’s degree in International Policy Studies from Stanford University. She received her MBA from Harvard Business School.

Kay Yun
Kay Yun is Chief Operating Officer. She is responsible for strategy, fundraising and operations.

Ms. Yun has over 20 years of business experience as an investment banker, a business development executive, CFO and CEO. Ms. Yun was an investment banker at Goldman, Sachs & Co. for more than nine years where she focused on key U.S. industrial clients. After leaving Goldman, Ms. Yun served as the CFO of a startup technology company. She later became co-founder and CEO of another technology company which she successfully sold to a strategic buyer. Ms. Yun also worked in business development at a Fortune 500 company, where she evaluated investment opportunities, established the private investment process and criteria, and served as a key member of a merger team that acquired a $4.3 billion technology company.

Ms. Yun is a trustee of the Bay Area Discovery Museum and was also a trustee of the Little School.

Ms. Yun received a BA from the University of Colorado, Boulder and an MBA from the University of Pennsylvania, Wharton School of Business.

ADVISORS

Richard Carmona, MD, MPH, FACS
17th Surgeon General of the United States (2002-2006)
Vice Chairman of Canyon Ranch and President, Canyon Ranch Institute
Distinguished Professor Zuckerman College of Public Health, University of Arizona

Molly Coye, MD, MPH
Founder and CEO of The Health Technology Center

David M. Lawrence, MD
Former chairman and CEO of Kaiser Permanente

Peter V. Lee
Executive director of national health policy for the Pacific Business Group on Health

Arnold Milstein, MD, MPH
Co-founder of The Leapfrog Group; national leadership in making health care markets conducive to high value innovations

Jack W. Rowe, MD
Former chairman and CEO of Aetna and president and CEO of Mount Sinai NYU Health

One of the ways Health Evolution Partners adds value to our limited partners and portfolio companies is through the Purchaser Value Initiative (PVI). The PVI is a coalition of state pension funds and large employers that work to accelerate adoption of promising innovations that have the potential to dramatically improve health care quality and lower costs. The six member organizations purchase more than $12 billion in health care services each year.

Greg Franklin
Assistant Executive Officer
California Public Employees Retirement System (CalPERS)

Robert S. Galvin, MD
Director, Global Health Care
General Electric Company

Nathan Moracco
Director, Employee Insurance Division
Minnesota State Employees Group Insurance Program

Kate Farley
Executive Director
Pennsylvania Employees Benefit Trust Fund

David Stella
Secretary
Wisconsin Department of Employee Trust Funds

Steve Hill
Administrator
Washington State Health Care Authority

21CM (21st Century Medicine) is a collaboration between Health Evolution Partners and select health care leaders that will identify innovations which change how medicine is practiced. Health Evolution Partners is working with 21CM leaders to survey societal trends, inventions, policies and economic changes that alter care delivery, and identify actions to be taken to bring these important innovations into broad use. Some of 21CM’s priorities include: patient quality and safety, telehealth, health care IT, personal health records, cost efficiency and consumerism. Our 21CM members represent diverse geographies, populations and health care systems.

Toby Cosgrove, MD
President and CEO
Cleveland Clinic

Will Ferniany, PhD
CEO
University of Alabama at Birmingham, Health System

Gary Gottlieb, MD, MBA
President
Brigham and Women's Hospital, Partners HealthCare System

George Isham, MD, MS
Medical Director and CHO
Health Partners

Gary S. Kaplan, MD
Chairman and CEO
Virginia Mason

Mark R. Laret
CEO
University of California, San Francisco Medical Center

Martha H. Marsh
President and CEO
Stanford Hospital & Clinics

Jonathan B. Perlin, MD, PhD, MSHA, FACP, FACMI
President, Clinical Services and CMO
HCA/Hospital Corporation of America

Thomas M. Priselac
President and CEO, Cedars Sinai Medical Center
Cedars Sinai Medical Center

Steven M. Safyer, MD
President and CEO
Montefiore Medical Center

Glenn Steele, JR, MD, PhD
President and CEO
Geisinger Health System